Frontiers in Medicine,
Journal Year:
2024,
Volume and Issue:
11
Published: Oct. 18, 2024
In
China,
diabetes
mellitus
(DM)
significantly
contributes
to
end-stage
renal
disease
(ESRD),
necessitating
treatments
like
hemodialysis.
This
study
investigates
hemodialysis
outcomes
in
diabetic
nephropathy
patients
Guizhou
Province,
aiming
enhance
care
for
this
high-risk
group.
World Journal of Diabetes,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: Nov. 29, 2024
The
onset
and
progression
of
type
2
diabetes
mellitus
(T2DM)
are
strongly
associated
with
imbalances
in
gut
bacteria,
making
the
microbiome
a
new
potential
therapeutic
focus.
This
commentary
examines
recent
publication
World
Journal
Diabetes
.
article
explores
association
between
T2DM
microbiota,
focus
on
pathophysiological
changes
related
to
dysbiosis.
It
proposes
innovative
microbiome-targeted
strategies
evaluates
challenges
future
directions
such
approaches.
editorial
summarizes
key
points
their
discussion
role
elaborates
influence
specific
microbial
species
disease
through
host–microbiota
metabolic
axis.
provides
insights
for
research
gut-microbiota-based
interventions
T2DM.
Journal of Translational Medicine,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: April 10, 2025
Knowledge
of
the
urinary
microbiome
(urobiome)
in
diabetic
kidney
disease
(DKD)
remains
limited.
The
most
commonly
used
16S
rRNA
sequencing
technique
can
only
provide
bacterial
identification
at
genus
level.
As
a
novel
technique,
2bRAD
for
(2bRAD-M)
be
to
identify
low-biomass
species
In
this
study,
we
2bRAD-M
compare
urobiome
composition
patients
with
DKD
different
stages
healthy
individuals
and
those
type
2
diabetes
mellitus
(T2DM),
expectation
that
would
find
discriminative
correlated
DKD.
Healthy
controls,
microalbuminuria
(DKD1
group)
or
macroalbuminuria
(DKD2
group),
T2DM
were
recruited
(n
=
20
each
group).
first-morning
urine
was
collected
testing.
albumin-to-creatinine
ratio
(ACR)
also
measured
samples.
Serum
samples
detecting
clinical
indicators.
microbial
diversity
based
on
abundance
calculated.
Differential
bacteria
groups
identified.
Besides,
correlation
between
indices
analyzed.
Urobiome
significantly
reduced
groups.
DKD1
group,
dominant
genus,
followed
by
Pseudomonas_E,
whereas
DKD2
Pseudomonas_E
became
Escherichia
notably
reduced.
Both
Bifidobacterium
Streptococcus,
which
top
genera
control
substantially
decreased
included
coli
Acinetobacter
johnsonii,
while
DKD2,
oleovorans,
Enterococcus
faecalis,
Morganella
morganii
showed
strong
renal
function
indicators
protein
levels.
markedly
from
patients.
These
findings
valuable
insights
into
onset
progression
DKD,
driven
changes
community
structure.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 3, 2024
Diphenyl
diselenide
(DPDS)
ameliorates
nephropathy
in
streptozotocin
(STZ)-induced
type
1
diabetic
rats
by
inhibiting
oxidative
stress
and
inflammatory
reactions.
However,
it
has
not
been
clarified
whether
DPDS
alleviates
kidney
disease
(DKD)
is
related
to
the
inhibition
of
extracellular
matrix
(ECM)
production
regulation
intestinal
flora
disorder.
Heliyon,
Journal Year:
2023,
Volume and Issue:
9(12), P. e22117 - e22117
Published: Nov. 10, 2023
It
aimed
to
explore
the
diversity
of
gut
microbiota
(GM)
and
effect
different
on
insulin
resistance
in
diabetes
mellitus
(DM)
patients
through
bioinformatics
analysis.Microarray
data
were
obtained
from
GEO
database.
GM
samples
DM
healthy
controls
collected,
16S
rRNA
gene
sequencing
was
carried
out
adopting
high-throughput
technology.
The
differential
expression
genes
screened
using
Qlucore
Omics
Explorer
3.0
software.
Subsequently,
online
tools
such
as
STRING
DAVID
utilized
for
analysis
genes.
differences
bacterial
between
evaluated
by
analyzing
indicators
microbiota,
Shannon
Chao1
indexes.
Differential
abundance
functional
prediction
adopted
its
possible
metabolic
pathways
controls.
And
specific
taxa
analyzed.GM
had
significant
differences.
lower
compared
with
controls,
indicated
a
decrease
showed
that
there
multiple
communities
including
some
at
genus-level.
Functional
also
revealed
potential
related
patients.
HEXB,
ZC3H12A,
CCR,
CXCR3,
GBR10,
CDK9,
TXN,
IGFBP3,
PDHA1,
NDUFB3
may
be
targets
treatment.There
are
occurrence
development
resistance.
Biomolecules,
Journal Year:
2024,
Volume and Issue:
14(9), P. 1153 - 1153
Published: Sept. 13, 2024
Deranged
gut
microbiota
can
release
increased
levels
of
uremic
toxins
leading
to
exacerbated
kidney
injury.
In
diabetic
disease
(DKD),
phenyl
sulfate
(PS)
derived
from
tyrosine
catabolism
by
has
been
demonstrated
be
both
an
early
diagnostic
marker
and
a
therapeutic
target.
this
perspective
article,
we
summarize
PS
generation
pathways
recent
findings
on
injury
in
DKD.
Increasing
evidence
shown
that
the
underlying
mechanisms
PS-induced
mainly
involve
oxidative
stress,
redox
imbalance,
mitochondrial
dysfunction,
which
all
may
targeted
attenuate
For
future
research
directions,
think
deeper
understanding
pathogenic
role
using
variety
animal
models
should
investigated.
Moreover,
also
suggest
beneficial
approaches
could
used
mitigate
deleterious
effect
kidney.
These
include
caloric
restriction,
administration
ketogenic
drugs,
diets
or
natural
products;
conducted
under
obese
conditions.
Pharmacological Research,
Journal Year:
2024,
Volume and Issue:
208, P. 107392 - 107392
Published: Sept. 2, 2024
Diabetic
nephropathy
(DN)
is
a
major
complication
of
diabetes
mellitus
(DM)
without
curative
interventions
currently.
Huperzine
A
(Hup
A),
natural
alkaloid,
has
demonstrated
significant
hypoglycemic
and
anti-inflammatory
effects.
We
aim
to
investigate
the
protective
effects
Hup
on
DN
explore
underlying
mechanisms
METHODS:
applied
STZ
induced
diabetic
rats
as
model
leveraged
combination
analysis
transcriptome,
metabolome,
microbiome,
network
pharmacology
(NP).
The
total
effect
was
detected
(i.e.
urine
protein,
renal
tissue
structure)
differential
genes
were
further
verified
at
level
patients,
db/db
mice
cells.
Clinical
data
small
interfering
RNA
(siRNA)-Apoe
adopted.
Metabolites,
Journal Year:
2023,
Volume and Issue:
13(8), P. 893 - 893
Published: July 28, 2023
Complications
due
to
type
2
diabetes
mellitus
(T2DM)
such
as
diabetic
kidney
disease
(DKD)
and
cerebral
small
vessel
(CSVD)
have
a
powerful
impact
on
mortality
morbidity.
Our
current
diagnostic
markers
become
outdated
T2DM-related
complications
continue
develop.
The
aim
of
the
investigation
was
point
out
relationship
between
previously
selected
metabolites
which
are
potentially
derived
from
gut
microbiota
indicators
endothelial,
proximal
tubule
(PT),
podocyte
dysfunction,
neurosonological
indices.
study
participants
were
20
healthy
controls
90
T2DM
patients
divided
into
three
stages:
normoalbuminuria,
microalbuminuria,
macroalbuminuria.
Serum
urine
determined
by
untargeted
targeted
metabolomic
techniques.
PT
dysfunction
assessed
ELISA
technique,
indices
provided
an
ultrasound
device
with
high
resolution
(MYLAB
8-ESAOTE
Italy).
descriptive
statistical
analysis
followed
univariable
multivariable
linear
regression
analyses.
In
conclusion,
in
serum,
arginine
(sArg),
butenoylcarnitine
(sBCA),
indoxyl
sulfate
(sIS)
expressed
biomarker
potential
terms
renal
endothelial
carotid
atherosclerosis,
whereas
sorbitol
(sSorb)
may
be
blood-brain
barrier
(BBB)
dysfunction.
urine,
BCA
IS
associated
damage,
PCS
correlated